introduction of bimatoprost ophthalmic solution, 0.03% (0.3 mg/mL), which is a generic version of Allergan’s Latisse.
Bimatoprost ophthalmic solution, 0.03%, is a prescription medicine indicated to treat hypotrichosis of the eyelashes by increasing their growth, including length, thickness and darkness.
"The launch of bimatoprost is an important addition to our industry-leading portfolio of ophthalmic products,” said Peter Goldschmidt, President of Sandoz Inc. “By expanding our ophthalmic offerings, Sandoz will increase patients’ access to a comprehensive range of quality medicines at affordable prices.”
According to IMS Health, US sales for Latisse were approximately USD 75 million for the twelve-month period ending in October. Sandoz is marketing bimatoprost in the same 0.03% strength as the branded product.
Important Safety Information
If you use/used prescription products for eye pressure problems, use bimatoprost under doctor care. Bimatoprost may cause increased brown pigmentation of the colored part of the eye, which is likely permanent. Eyelid skin darkening may occur and may be reversible. Only apply at the base of upper lashes. DO NOT APPLY to lower lid. Hair may grow on skin that bimatoprost frequently touches. If you have eye problems/surgery, consult your doctor about use of bimatoprost. Common side effects are itchy and red eyes. If discontinued, lashes gradually return to previous appearance.
0 comments:
Note: only a member of this blog may post a comment.